Zevin Asset Management LLC Has $9.83 Million Stock Position in Colgate-Palmolive Company $CL

Zevin Asset Management LLC reduced its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 6.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 122,990 shares of the company’s stock after selling 8,356 shares during the quarter. Colgate-Palmolive makes up approximately 1.4% of Zevin Asset Management LLC’s holdings, making the stock its 29th biggest position. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $9,832,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Norges Bank acquired a new stake in Colgate-Palmolive in the 2nd quarter valued at $960,390,000. Schroder Investment Management Group grew its holdings in shares of Colgate-Palmolive by 242.3% in the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock valued at $483,962,000 after acquiring an additional 3,768,784 shares in the last quarter. Pacer Advisors Inc. increased its position in shares of Colgate-Palmolive by 3,052.2% in the third quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock valued at $215,602,000 after acquiring an additional 2,611,485 shares during the last quarter. Diamond Hill Capital Management Inc. raised its holdings in Colgate-Palmolive by 46.7% during the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock worth $645,719,000 after acquiring an additional 2,572,796 shares in the last quarter. Finally, Acadian Asset Management LLC raised its holdings in Colgate-Palmolive by 42.9% during the second quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock worth $556,663,000 after acquiring an additional 1,839,853 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on CL. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target for the company in a research note on Tuesday, December 9th. UBS Group boosted their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 13th. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research report on Monday, February 2nd. Finally, Citigroup raised their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $95.07 on Monday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a market capitalization of $76.63 billion, a price-to-earnings ratio of 36.29, a PEG ratio of 4.29 and a beta of 0.29. The company has a 50-day simple moving average of $85.61 and a 200 day simple moving average of $82.25. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 earnings per share. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares in the company, valued at $1,018,691.15. The trade was a 59.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 184,683 shares of company stock worth $17,486,693. Insiders own 0.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.